Compass
AI Equity Research
Start free for 3 days
AI Equity Research · Healthcare

GMR Solutions Inc. (GMRS)

AI stock analysis · Medical Care Facilities · Last analyzed Jul 8, 2026

Compass Score
4.0/5
Call
Buy
Price
$15.84
AI Target
$19.38 +22.3%
AI Analyst Summary

GMR Solutions Inc. trades at a deeply discounted trailing P/E of 8.2x — well below sector norms — while commanding near-unanimous analyst support (7 Buy, 1 Hold, 0 Sell), suggesting the market has yet to fully price in the company's fundamental value. Revenue growth of 6.6% YoY provides a constructive top-line backdrop, and the analyst consensus price target of $19.38 implies over 22% upside from current levels. The primary risk is limited earnings transparency, as the absence of EPS history and forward growth data makes it difficult to validate whether the low multiple reflects deep value or underlying profitability concerns.

Catalysts
Risks
Fundamentals
Pe Trailing P/E: 8.2x · 5.0/5
Trailing P/E of 8.2x is materially below the Healthcare/Medical Care Facilities sector median, representing a compelling valuation discount that appears growth-justified given positive revenue momentum.
Peg PEG Ratio: N/A · 3.0/5
PEG ratio is unavailable due to missing earnings growth data. Defaulting to neutral score of 3; the low P/E is a positive offset but insufficient growth visibility prevents a higher score.
Analyst Rating Strong Buy consensus (1.1) · 5.0/5
7 Buy and 1 Hold across 8 analysts yields an implied consensus of approximately 1.1 on the inverted scale — a near-unanimous bullish signal with no sell-side dissent and sufficient analyst coverage to validate the score.
Earnings Trend Revenue growth 6.6% YoY; EPS growth N/A · 3.0/5
Revenue growth of 6.6% YoY is modest but positive. Earnings growth data is unavailable, limiting visibility into bottom-line momentum. Neutral score reflects the partial picture — revenue trajectory is constructive but EPS trend cannot be confirmed.
Price Target Beat EPS beat rate: Insufficient history (0 quarters) · 3.0/5
No quarterly EPS beat history is available, defaulting to a neutral score of 3 per scoring guidelines. Execution track record cannot be assessed at this time.
Management Limited execution history; strong analyst confidence · 3.0/5
With no EPS beat history to draw from, management quality is inferred primarily from the near-unanimous bullish analyst consensus. This suggests market confidence in leadership, but the absence of a track record warrants a conservative neutral score.
See the full picture
Get today's top-scored picks, ranked for you.

Compass screens thousands of stocks every morning and hands you a short list of high-conviction picks — scored, explained, and re-ranked to your risk profile.

Start free for 3 days →
No credit card. Then $9/month. Cancel anytime.
How Compass scores stocks

Compass pre-filters thousands of U.S. equities by fundamentals, then an AI analyst scores each finalist 1–5 across six measures — spanning valuation, growth, analyst sentiment, and management quality — into one composite score, refreshed every market morning. Browse all covered stocks →

Not financial advice. Compass is an analytical tool, not a registered investment adviser or broker-dealer. Scores and recommendations are generated by AI, may be inaccurate or out of date, and are not investment, financial, legal, or tax advice. Investing involves risk, including loss of principal. Do your own research and consult a licensed financial professional. About Compass.